Product Information
ATAZANAVIR SULFATE 300 MG CAP is a generic product labeled by Laurus Labs Limited, priced at $2.5602 per EA under NDC 42385092230. Its NADAC has been published 194 times since Mar 16, 2022.
Strength
300 mg/1
Manufacturer
Laurus Labs LimitedNDC
42385092230
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
ATAZANAVIR SULFATEApproval Type
Generic (ANDA)
FDA Application
ANDA212579On Market Since
4/30/2021
Pharmacological Classes
Price Statistics
The NADAC for ATAZANAVIR SULFATE 300 MG CAP has been published 194 times since Mar 16, 2022, and over the history we have for it it has declined 56.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.5602 per EA |
|---|---|
| All-time high | $5.9101 (May 11, 2022) |
| All-time low | $1.7959 (Aug 21, 2024) |
| 52-week high | $3.4622 |
| 52-week low | $2.5602 |
| Median price | $3.3892 |
| Average price | $3.1887 |
| Largest weekly change | +41.4% (Oct 23, 2024) |
| Weeks tracked | 194 |
| Tracking since | Mar 16, 2022 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of ATAZANAVIR SULFATE 300 MG CAP?
The current National Average Drug Acquisition Cost (NADAC) for ATAZANAVIR SULFATE 300 MG CAP, manufactured by Laurus Labs Limited, is $2.5602 per EA (NDC 42385092230), effective Jun 24, 2026.
How has the price of ATAZANAVIR SULFATE 300 MG CAP changed over time?
Over the history we have for it, the NADAC for ATAZANAVIR SULFATE 300 MG CAP has declined 56.7%. It has been tracked across 194 weekly CMS publications since Mar 16, 2022.
What are the highest and lowest recorded NADAC prices for ATAZANAVIR SULFATE 300 MG CAP?
Since Mar 16, 2022, the NADAC for ATAZANAVIR SULFATE 300 MG CAP has ranged from a low of $1.7959 (Aug 21, 2024) to a high of $5.9101 (May 11, 2022), with a median of $3.3892 per EA.
Are there cheaper alternatives to ATAZANAVIR SULFATE 300 MG CAP?
2 NADAC-published products share the same active ingredient, strength, and dosage form as ATAZANAVIR SULFATE 300 MG CAP, but none are currently priced below it.
Who manufactures ATAZANAVIR SULFATE 300 MG CAP?
ATAZANAVIR SULFATE 300 MG CAP (NDC 42385092230) is labeled by Laurus Labs Limited, and CMS classifies it as a generic product.
Related Drugs
Same classification